Additionally, tumor cells expressing the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) synthesize active glucocorticoids, which suppress CD8+ T cell activation and promote Treg functions, enhancing tumor progression. Here, CD8A is linked to neoplasm.